(Reuters) - Biopharmaceutical company Progenics Pharmaceuticals Inc said it reduced its workforce by 26 percent to focus on mid-stage studies of its experimental prostrate cancer drug. As part of the restructuring, Chief Financial Officer Robert M...
Source: http://health.yahoo.net/news/s/nm/progenics-pharmaceuticals-to-reduce-26-percent-of-its-workforce
Jorja Fox history Facebook funny
No comments:
Post a Comment
Note: only a member of this blog may post a comment.